Futura Medical

Futura's innovation strategy applies advanced science to develop products with compelling commercial potential using our advanced proprietary transdermal technology. Based in Surrey, UK, the company's shares trade on the AIM market of the London Stock Exchange. Futura's development pipeline focuses on sexual healthcare and pain relief management and we are evaluating further therapeutic opportunities as potential additions to the pipeline. Futura is gaining recognition within the pharmaceutical industry for its strengths in transdermal drug delivery technology. We have a number of relationships with key players.
Type
Public
HQ
Guildford, GB
Founded
1997
Employees
8 (est)+60%

Key People at Futura Medical

Bill Potter

Bill Potter

CSO
James Barder

James Barder

CEO

Futura Medical Locations

Guildford, GB

Futura Medical Metrics

Futura Medical Summary

Founding Date

1997

Market capitalization

£58.7 M

Closing share price

£0.603

Futura Medical Financials

FY, 2013FY, 2014FY, 2015

Revenue

£371 K£43.9 K£29.5 K

Revenue growth, %

-88.2%-32.9%

Futura Medical Market Value History

Futura Medical News

Futura Medical Company Life

You may also be interested in